Observational Study in Adults With Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated With Nilotinib

NCT01475110 · clinicaltrials.gov ↗

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myeloid Leukaemia

Interventions

DRUG: Imatinib

Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto